Organogenesis (ORGO) Holdings announced plans to expand manufacturing capacity with a long-term lease for a 122,000-square foot state-of-the-art biomanufacturing facility located at 100 Technology Way ...
Organogenesis (ORGO) Holdings announced that it has entered into a subscription agreement with affiliates of Avista Healthcare Partners for the sale of its Series A convertible preferred stock in a ...
Organogenesis Holdings Inc. (NASDAQ: ORGO) shared topline data on Thursday from the second Phase 3 randomized controlled trial (RCT) of ReNu, a cryopreserved amniotic suspension allograft (ASA) for ...
PROVIDENCE — Rhode Island Commerce Corporation has granted Organogenesis, a Massachusetts biotech firm, more than $13 million in tax incentives, to support the company’s opening of a new manufacturing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results